No CrossRef data available.
Article contents
An unusual course of anti-Ro antibody-mediated fetal complete heart block
Published online by Cambridge University Press: 07 November 2017
Abstract
Fetal hydrops is a serious complication of immune-mediated congenital complete atrioventricular block. We present the case of a fetus with severe hydrops and profound bradycardia and an unusual favourable outcome. This case enhances the importance of considering the contribution of ventricular ectopic beats to the cardiac output when counselling and predicting outcome of complete heart block.
- Type
- Brief Report
- Information
- Copyright
- © Cambridge University Press 2017
References
1.
Brucato, A, Cimaz, R, Caporali, R, et al. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol
2011; 40: 27–41.CrossRefGoogle ScholarPubMed
2.
Gladman, G, Silverman, ED, Yuk, L, et al. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies. Am J Perinatol
2002; 19: 73–80.CrossRefGoogle ScholarPubMed
3.
Jaeggi, ET, Fouron, JC, Silverman, ED, et al. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation
2004; 110: 1542–1548.CrossRefGoogle ScholarPubMed
4.
Hutter, D, Silverman, ED, Jaeggi, ET. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review. Scand J Immunol
2010; 72: 235–241.CrossRefGoogle ScholarPubMed
5.
Jaeggi, E, Laskin, C, Hamilton, R, et al. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol
2010; 55: 2778–2784.CrossRefGoogle ScholarPubMed
6.
Jaeggi, ET, Hamilton, RM, Silverman, ED, et al. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution’s experience of 30 years. J Am Coll Cardiol
2002; 39: 130–137.CrossRefGoogle ScholarPubMed
7.
Groves, AM, Allan, LD, Rosenthal, E. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation
1995; 92: 3394–3396.CrossRefGoogle ScholarPubMed
8.
Eliasson, H, Sonesson, SE, Sharland, G, et al. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients. Circulation
2011; 124: 1919–1926.CrossRefGoogle ScholarPubMed
9.
Chockalingam, P, Jaeggi, ET, Rammeloo, LA, et al. Persistent fetal sinus bradycardia associated with maternal anti-SSA/Ro and anti-SSB/La antibodies. J Rheumatol
2011; 38: 2682–2685.CrossRefGoogle ScholarPubMed
10.
Wakisaka, Y, Niwano, S, Niwano, H, et al. Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure. Cardiovasc Res
2004; 63: 689–699.CrossRefGoogle ScholarPubMed
11.
Lopes, LM, Tavares, GM, Damiano, AP, et al. Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution. Circulation
2008; 118: 1268–1275.CrossRefGoogle ScholarPubMed